---
title: "DC 6819 - Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths"
diagnostic_code: "6819"
body_system: "Respiratory System"
cfr_section: "§ 4.97"
canonical: "https://veteranai.co/va-rating-schedule/respiratory/6819-neoplasms-malignant-any-specified-part-of-respiratory-system"
source: "https://www.ecfr.gov/current/title-38/section-4.97"
updated: "2026-07-21T03:43:55.987383Z"
---

# DC 6819 - Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths

Rated under § 4.97. Body system: Respiratory System.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths |

## Notes

- Note: A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.

# Malignant Respiratory System Neoplasms (VA Diagnostic Code 6819)

*Respiratory System · 38 CFR § 4.97*

## Understanding This Condition

Diagnostic Code 6819 covers **malignant neoplasms (cancers) of any specified part of the respiratory system, excluding skin growths**. This is the rating category the VA uses for active malignant conditions affecting the respiratory system.

## Available Rating Level

Under Diagnostic Code 6819, there is a single rating level:

| Rating | Criteria |
|--------|----------|
| **100%** | Neoplasms, malignant, any specified part of the respiratory system (exclusive of skin growths) |

## What the VA Looks For

**Continuation of the 100% rating during treatment.** A rating of 100 percent continues beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure.

**Mandatory re-examination after treatment ends.** Six months after such treatment is discontinued, the appropriate disability rating is determined by a mandatory VA examination.

**How changes are handled.** Any change in evaluation based on that examination — or any subsequent examination — is subject to the provisions of § 3.105(e).

**Rating based on residuals.** If there has been no local recurrence or metastasis, the condition is rated based on its residuals.

---

*This information is drawn directly from the VA rating schedule (38 CFR § 4.97) for Diagnostic Code 6819. It is provided for general educational purposes and does not constitute legal advice or a guarantee of any rating outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.97